glp 1 agonist trade name GLP-1 Agonists for Weight Loss: Safe or Risky? Oral GLP-1 receptor agonists are

Because of their diverse biological effects, these drugs hold promise for delivering therapeutic benefits in a wide range of human diseases

The compounding difference Compounded tirzepatide and compounded semaglutide are prepared by compounding pharmacies and may contain different excipients (inactive ingredients), different concentrations, and different purity profiles than FDA-approved formulations

AFC, antral follicle count

It takes time to get a firm grasp of the true risk profile of a drug

and global prevalence of type 2 diabetes and obesity, advancements in drug development, and expanding indications for weight loss and cardiovascular health

Interestingly, agmatine, a metabolite produced by the gut bacterium Bacteroides vulgatus was shown to impair ovarian function by inhibiting GLP-1 secretion through activation of the farnesoid X receptor (FXR) (Yun et al., 2024)